Results 61 to 70 of about 2,141 (223)
Florid follicular hyperplasia PTLD [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2018 Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of transplantation, which represent a heterogeneous group of lymphoproliferative diseases and show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas.openaire +2 more sourcesIntestinal transplantation in Australia: Progress, challenges and future directions
Internal Medicine Journal, EarlyView.Abstract Background
Intestinal transplant is a rare procedure reserved for patients with intestinal failure who cannot be sustained on total parenteral nutrition due to severe, life‐threatening complications. This study aims to describe the activity and outcomes of intestinal transplantation undertaken in Australia.Brooke Chapman, Darren Wong, Graham Starkey, Marcos Perini, Jason Yap, Adam Testro +5 morewiley +1 more sourceHLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort [PDF]
, 2015 Granični poremećaj ličnosti je učestali psihički poremećaj koji se manifestira kroz simptome afektivne nestabilnosti, impulzivnog i nekontroliranog ponašanja, poremećaj identiteta, nestabilne interpersonalne odnose i moguće pogreške u testiranju ...Vase, Maja Ølholm, Maksten, Eva Futtrup, Strandhave, Charlotte, Søndergaard, Esben, Bendix, Knud, Hamilton-Dutoit, Stephen, Andersen, Claus, Møller, Michael Boe, Schwartz Sørensen, Søren, Kampmann, Jan Dominik, Eiskjaer, Hans, Iversen, Martin, Weinreich, Ilse Duus, Møller, Bjarne, Jespersen, Bente, d'Amore, Francesco +15 morecore +1 more sourceEpstein-Barr virus: clinical and epidemiological revisits and genetic basis of oncogenesis [PDF]
, 2015 Epstein-Barr virus (EBV) is classified as a member in the order herpesvirales, family herpesviridae, subfamily gammaherpesvirinae and the genus lymphocytovirus. The virus is an exclusively human pathogen and thus also termed as human herpesvirus 4 (HHV4).Abdel-Hamid M., Abdelwahid Saeed Ali, Aboulola M., Ahmed Musa Al-Hakami, Akiba S., Aldoss I.T., Allan G.J., Allday M.J., Alsayed Y., Amon W., Anagnostopoulos I., Anagnostopoulos I., Andersson-Anvret M., Anwar N., Arber D.A., Armstrong A.A., Arvey A., Baer R., Bargou R.C., Bellan C., Bernasconi N.L., Bhatia K., Bilodeau E., Birkenbach M., Borchmann P., Borza C.M., Brady G., Brink A.A., Brooks L., Burgess D.E., Burkitt D., Béogo R., Calderwood M.A., Capello D., Carter K.L., Chapple I.L., Chen C.J., Chen C.L., Cheng Y.J., Cherry-Peppers G., Chitgopeker P., Countryman J., Crawford D.H., Croft N.P., D. Burkitt, Dadmanesh F., Dave S.S., de-The G., Deacon E.M., Derenzini E., Dotti G., Dunleavy K., Dürkop H., Ebell M.H., Epstein M.A., Faggioni A., Falk K., Farrell P.J., Feederle R., Feederle R., Feng W.H., Ferry J.A., Fingeroth J.D., Flavell K.J., Flavell K.J., Fruehling S., Fujii T., Gabusi E., Galetsky S.A., George T.I., Gires O., Glaser S.L., Gonzalez-Moles M.A., Gordadze A.V., Gottschalk S., Greenspan D., Gregory C.D., Gregory C.D., Grossman S.R., Gulley M.L., Gulley M.L., Gutensohn N., Hammerschmidt W., Hardwick J.M., Harn H.J., Hatzubai A., Henderson E., Henderson S., Henle G., Henle G., Henle W., Herbst H., Hildesheim A., Hjalgrim H., Huang W., Hutzinger R., Ian M Jones, Imai S., Imai S., Jochum S., Johannessen I., Johannessen I., Kang Myung-Soo, Khan G., Khanim F., Kim Y.C., Klein G., Kubuschok B., Küppers R., Küppers R., Lau R., Laux G., Lee H.S., Leoncini L., Levine P.H., Lin Z., Lockey T.D., Loren A.W., Lung M.L., Ma L., MacMahon B., Macsween K.F., Maeda E., McGeoch D.J., Meijer C.J., Merlo A., Meyer R.M., Miller G., Minoura-Etoh J., Miranda C., Moore M.D., Moormann A.M., Mraz-Gernhard S., Mubarak Al-Shraim, Mueller N., Murray P.G., Murray P.G., Neitzel H., Nelson B.P., Neri A., Nerurkar A.Y., Niedobitek G., Niedobitek G., Niedobitek G., Niedobitek G., Odumade O.A., Okano M., Okebe J.U., Otsuka H., Ott G., Packham G., Pallesen G., Parker Bruce D, Pavlova S., Payne D.A., Pelloquin F., Phillips J.A., Piccaluga P.P., Pioche-Durieu C., Pitman S.D., Poirel H.A., Pope J.H., Pressman S., Qiu K., Raab-Traub N., Raab-Traub N., Raab-Traub N., Razzouk B.I., Ressing M.E., Rowlands D.C., Saemundsen A.K., Sample J., Savage K.J., Savage K.J., Seki D., Sham J.S., Shibata D., Shibata D., Shibata D., Shin W.S., Simons M.J., Sitki-Green D., Sixbey J.W., Smir B.N., Sriamporn S., Stadlmann S., Stefan D.C., Stein H., Su I-J., Sugiura M., Swinnen L.J., Takada K., Thorley-Lawson D.A., Thorley-Lawson D.A., Tierney R.J., Timens W., Tokunaga M., Tovey M.G., Traggiai E., Tso K.K., Uccini S., Uchida J., Umene K., van den Bosch C.A., van Zijl M., Vo Q.N., Walling D.M., Walling D.M., Weinberg E., Weiss L.M., Wu T.C., Xiao J., Yanai H., Young L., Young L.S., Young L.S., Young L.S., Yu M.C., Yu M.C., Yuen S.T., Zeng M-S., Zeng M.S., Zimber-Strobl U., zur Hausen H., zur Hausen H. +224 morecore +1 more sourceTransfusion‐related alpha‐gal syndrome: Two new cases expanding the demographic and geographic spectrum, and evidence of a diagnostic gap in allergic transfusion reaction evaluation
Transfusion, EarlyView.Abstract Background
Transfusion‐related alpha‐gal syndrome (TRAGS) has recently been proposed as a cause of allergic transfusion reactions (ATRs) in which alpha‐gal‐specific IgE in sensitized group O (or potentially group A) recipients reacts with epitopes on group B or AB plasma‐containing components.Mackenzie Foster, Miriam Brown, Angela Mueller, Toufik Tahiri, Kaycie Atchison, Deva Sharma, Cosby A. Stone Jr., Jonathan Tucci, Garrett S. Booth, Jeremy W. Jacobs +9 morewiley +1 more sourceCumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients
International Journal of Cancer, Volume 158, Issue 12, Page 3152-3160, 15 June 2026.What's new?
Long‐term immunosuppression in solid organ transplant recipients (SOTRs) is linked to increased cancer risk. Although this risk potentially increases with greater immunosuppressant exposure, the exact dose‐response pattern remains uncertain.Sergio A. Acuna, Xun Zhao, Maggie Jones‐Carr, Graham Smith, Kyla Naylor, Bima J. Hasjim, Shiyi Chen, An‐Wen Chan, Nancy Baxter, S. Joseph Kim, Mamatha Bhat +10 morewiley +1 more sourceTherapy of lyme disease [PDF]
, 2016 Borrelia burgdorferi is highly susceptible to antibiotic treatment and the majority of patients profit from this treatment. Antibiotic selection, dose and route of administration, and duration of therapy for Lyme disease depend on the patient\u2019s ...di Meo, Nicola, Errichetti, Enzo, Nan, Katiuscia, Pinzani, Caterina, Stinco, Giuseppe, Trevisan, Giusto +5 morecore +1 more sourceLiver Transplantation Outcomes in Crigler‐Najjar Syndrome in Iran: A Single‐Center Retrospective Cohort Study Over 20 Years
Health Science Reports, Volume 9, Issue 5, May 2026.ABSTRACT Background and Aims
Crigler‐Najjar Syndrome (CNS) is a rare autosomal recessive disorder caused by uridine diphosphate glucuronosyltransferase (UGT1A1) deficiency, leading to unconjugated hyperbilirubinemia. Without treatment, patients are at high risk of kernicterus and irreversible neurological damage.Sajad Teimoury, Zahra Beyzaei, Alireza Shamsaeefar, Kurosh Kazemi, Saman Nikeghbalian, Seyed‐Ali Malekhosseini, Bita Geramizadeh +6 morewiley +1 more sourceLyme disease and the pursuit of a clinical cure
Frontiers in Medicine, 2023 Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-borne illness in the United States. Many aspects of the disease are still topics of controversy within the scientific and medical communities.Heather Adkison, Monica E. Embersdoaj +1 more source